Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat

E-ISSN： 1099-1069|36|1|360-362

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 360-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacokinetic Enhancement of Protease Inhibitor Therapy

By King J.R.

Clinical Pharmacokinetics, Vol. 43, Iss. 5, 2004-01 ,pp. : 291-310

Adis International

Access to resources Recommend Favorite

Heparanase as a Target in Cancer Therapy

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 286-293

Bentham Science Publishers

Access to resources Recommend Favorite

The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy

By Becker Stephen L

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 401-412

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy

Current Molecular Pharmacology, Vol. 2, Iss. 3, 2009-11 ,pp. : 263-284

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Glioma Microenvironment in Immune Modulation: Potential Targets for Intervention

Letters in Drug Design & Discovery, Vol. 3, Iss. 7, 2006-09 ,pp. : 443-453

Bentham Science Publishers

Access to resources Recommend Favorite